UNSPSC 51141528: Topiramate

This classification denotes an anticonvulsant agent with the molecular formula C12H21NO8S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0H73WJJ391, chemically known as 2,3:4,5-bis-o-isopropylidene-.beta.-d-fructopyranose sulfamate but generally known as topiramate, which bears US NIH Compound Identifier 5514. European Medicines Agency schedules Topiramate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11190MIG.

UNSPSC 51141528 Topiramate is a Commodity code that should designate individual pharmaceutical products, but the recent state and local opportunities posted under it cover a broader pharmaceutical procurement activity: emergency response medications (naloxone), safe drug deactivation systems, direct-to-manufacturer prescription programs, and multi-source generic pharmaceuticals and over-the-counter products supplied through authorized wholesalers. State and local governments procuring under this code are county health departments, state health and human services agencies, and multistate cooperative purchasing alliances that aggregate demand across multiple jurisdictions and public entities. The actual buying pattern spans emergency health supplies, pharmacy benefit program management, and bulk generic pharmaceutical sourcing for institutional distribution rather than a single molecule or branded product.

Recent activity shows Seminole County, Florida posting an IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building; the Texas Health and Human Services Commission issuing an RFI (HHS0017013, due April 3, 2026) to explore direct-to-manufacturer prescription contracting outside traditional pharmacy benefit manager and group purchasing organization channels; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) administering an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be supplied through three authorized wholesalers to participating state and local government facilities including Oregon. Geographic activity spans Florida, Texas, and the Upper Midwest with multistate cooperative reach. The code shows material recent activity but with a significant mismatch between its nominal scope (a single antiepileptic drug) and the breadth of pharmaceutical procurement actually tagged to it in state and local systems.